New imaging agent could sharpen pituitary tumor diagnosis
NCT ID NCT07254104
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 21 times
Summary
This early-phase study tests a new PET imaging agent called [68Ga]Ga-NOTA-RF in 30 adults with pituitary tumors. The goal is to see if it can better show tumor details and help doctors classify tumor types. Participants will receive the imaging agent and undergo a PET scan to measure how the tumor takes it up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITUITARY NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Medical College Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.